亚太地区常染色体显性多囊肾病患者快速进展的临床特征
这项跨国回顾性观察队列研究纳入亚太地区768例ADPKD患者,其中426例为快速进展者。快速进展者中囊感染、囊出血和蛋白尿更常见,且进展至终末期肾病的比例更高(13.9% vs 2.1%)。基于历史eGFR下降的快速进展标准与2年随访期间eGFR变化相关性最强。
要点
- 768例ADPKD患者中426例为快速进展者,其中210例基于历史eGFR下降标准判定。
- 快速进展者囊感染、囊出血和蛋白尿发生更频繁。
- 快速进展者与慢进展者进展至ESKD的比例分别为13.9%和2.1%。
核心结论
- 在亚太地区ADPKD患者中,应采用多种评估策略识别快速进展者;随访期间快速进展者囊感染、囊出血和蛋白尿更常见,且更多患者进展至ESKD。
研究设计与样本
- 跨国回顾性观察队列研究,纳入来自澳大利亚、中国、韩国、台湾和土耳其五家医院的768例ADPKD患者,快速进展者按ERA-EDTA指南定义并与慢进展者比较。
主要发现
- 210例通过历史eGFR下降满足快速进展标准,5例通过历史身高校正总肾脏体积增加满足标准。
- 随访期间快速进展者囊感染、囊出血和蛋白尿发生更频繁。
- 快速进展者和慢进展者分别有13.9%和2.1%进展至ESKD。
- 基于历史eGFR下降的快速进展标准与2年随访期间eGFR变化相关性最强。
临床怎么用
- 在亚太地区ADPKD患者的真实临床实践中,随访期间应采用多种评估策略识别快速进展者。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aimed to determine the utility of different methods to predict rapid progressors (RPs) and their clinical characteristics in Asia-Pacific patients with autosomal dominant polycystic kidney disease (ADPKD). METHODS: This was a multinational retrospective observational cohort study of patients with ADPKD in the Asia-Pacific region. Five hospitals from Australia, China, South Korea, Taiwan, and Turkey participated in this study. RP was defined by European Renal Association-European Dialysis and Transplantation Association (ERA-EDTA) guidelines and compared to slow progressors (SPs). RESULTS: Among 768 patients, 426 patients were RPs. Three hundred six patients met only 1 criterion and 120 patients satisfied multiple criteria for RP. Historical estimated glomerular filtration rate (eGFR) decline fulfilled the criteria for RP in 210 patients. Five patients met the criteria for a historical increase in height-adjusted total kidney volume (TKV). The 210 patients satisfied the criteria for based on kidney volume. During the follow-up period, cyst infections, cyst hemorrhage, and proteinuria occurred more frequently in RP; and 13.9% and 2.1% of RPs and SPs, respectively, progressed to end-stage kidney disease (ESKD). RP criteria based on historical eGFR decline had the strongest correlation with eGFR change over a 2-year follow-up. CONCLUSION: Various assessment strategies should be used for identifying RPs among Asian-Pacific patients with ADPKD in real-world clinical practice during the follow-up period, cyst infections, cyst hemorrhage, and proteinuria occurred more frequently; and more patients progressed to ESKD in RPs compared with SPs.
引用
- Oh YK, Ryu H, Ahn C, et al. Clinical Characteristics of Rapid Progression in Asia-Pacific Patients With ADPKD. Kidney Int Rep. 2023. PMID: 37705904. doi:10.1016/j.ekir.2023.06.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。